POLA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.763800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.919800E-01
Normal-vs-Stage2
4.959400E-01
Normal-vs-Stage3
2.335900E-02
Normal-vs-Stage4
9.869000E-01
Stage1-vs-Stage2
5.908000E-01
Stage1-vs-Stage3
3.999800E-03
Stage1-vs-Stage4
7.554600E-01
Stage2-vs-Stage3
2.156100E-03
Stage2-vs-Stage4
4.211000E-01
Stage3-vs-Stage4
1.481370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.832000E-01
Normal-vs-AfricanAmerican
9.874000E-01
Normal-vs-Asian
2.217800E-01
Caucasian-vs-AfricanAmerican
3.403000E-01
Caucasian-vs-Asian
2.949000E-01
AfricanAmerican-vs-Asian
1.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.729800E-01
Normal-vs-Female
6.133000E-01
Male-vs-Female
2.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.912400E-01
Normal-vs-Age(41-60Yrs)
7.862200E-01
Normal-vs-Age(61-80Yrs)
3.566200E-01
Normal-vs-Age(81-100Yrs)
3.097800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.604800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.004800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.086400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.775800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.190400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.835800E-01
Normal-vs-Daily Drinker
4.885000E-01
Normal-vs-Weekly Drinker
6.561200E-01
Normal-vs-Occasional Drinker
8.999200E-01
Normal-vs-Social Drinker
7.551200E-01
Non Drinker-vs-Daily Drinker
7.684200E-01
Non Drinker-vs-Weekly Drinker
6.239200E-01
Non Drinker-vs-Occasional Drinker
1.121040E-01
Non Drinker-vs-Social Drinker
2.058200E-01
Daily Drinker-vs-Weekly Drinker
7.887000E-01
Daily Drinker-vs-Occasional Drinker
2.864200E-01
Daily Drinker-vs-Social Drinker
4.335000E-01
Weekly Drinker-vs-Occasional Drinker
5.288000E-01
Weekly Drinker-vs-Social Drinker
6.913600E-01
Occasional Drinker-vs-Social Drinker
7.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.919400E-01
Normal-vs-Grade 2
8.034600E-01
Normal-vs-Grade 3
8.416600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.433000E-01
Grade 1-vs-Grade 3
2.277000E-01
Grade 1-vs-Grade 4
7.919400E-01
Grade 2-vs-Grade 3
2.276800E-01
Grade 2-vs-Grade 4
8.034600E-01
Grade 3-vs-Grade 4
8.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.366800E-01
Normal-vs-NonDiabetic
4.800600E-01
Diabetic-vs-NonDiabetic
3.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.615400E-01
Normal-vs-NoPancreatitis
4.382600E-01
Pancreatitis-vs-NoPancreatitis
6.635000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.466000E-01
Normal-vs-N1
5.116800E-01
N0-vs-N1
8.971400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.682600E-01
Normal-vs-TP53-NonMutant
7.046600E-01
TP53-Mutant-vs-TP53-NonMutant
1.939420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
